1. Home
  2. SBCF vs HAE Comparison

SBCF vs HAE Comparison

Compare SBCF & HAE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

SBCF

Seacoast Banking Corporation of Florida

HOLD

Current Price

$31.92

Market Cap

2.9B

Sector

Finance

ML Signal

HOLD

Logo Haemonetics Corporation

HAE

Haemonetics Corporation

HOLD

Current Price

$77.47

Market Cap

2.8B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SBCF
HAE
Founded
1926
1971
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Medical/Dental Instruments
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.9B
2.8B
IPO Year
2009
1996

Fundamental Metrics

Financial Performance
Metric
SBCF
HAE
Price
$31.92
$77.47
Analyst Decision
Buy
Buy
Analyst Count
1
9
Target Price
$38.00
$84.13
AVG Volume (30 Days)
612.5K
949.6K
Earning Date
04-28-2026
05-07-2026
Dividend Yield
2.43%
N/A
EPS Growth
10.56
N/A
EPS
0.29
2.05
Revenue
N/A
$910,373,000.00
Revenue This Year
$45.04
N/A
Revenue Next Year
$6.30
$5.23
P/E Ratio
$108.00
$38.95
Revenue Growth
N/A
N/A
52 Week Low
$24.46
$47.32
52 Week High
$35.55
$87.32

Technical Indicators

Market Signals
Indicator
SBCF
HAE
Relative Strength Index (RSI) 63.05 73.01
Support Level $29.30 $48.98
Resistance Level $32.12 $86.72
Average True Range (ATR) 0.62 3.04
MACD 0.22 1.24
Stochastic Oscillator 97.46 73.64

Price Performance

Historical Comparison
SBCF
HAE

About SBCF Seacoast Banking Corporation of Florida

Seacoast Banking Corp of Florida is a holding company. The company provides integrated financial services, including commercial and consumer banking, wealth management, and mortgage and insurance services, to customers across Florida through branch, mobile, and online banking solutions. It maintains day-to-day operations, particularly in the areas of operations, treasury management systems, information technology, and security. The company has one reportable segment that provides these integrated financial services, with segment revenues driven mainly by interest and fees on loans, interest on cash and cash equivalents, and investment securities, and fees on depository products and services.

About HAE Haemonetics Corporation

Haemonetics Corp aims to improve patient care and reduce the cost of healthcare by providing medical products and solutions in the blood and plasma component collection, surgical suite, and hospital transfusion service spaces. As such, the company operates under three segments: plasma, blood center, and hospital. The company primarily emphasizes its plasma and hospital segments due to their robust growth potential, whereas the blood center segment tends to be constrained by higher competition. Product revenue is driven by demand for disposable blood component collection and processing sets and the related equipment needed for proper functionality.

Share on Social Networks: